Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients-Reference-Cited by-同舟云学术

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients

Published:2019-09-03 Issue:4-5 Volume:43 Page:296-299
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Christen Jacques-Robert¹,Bertolino Julien¹,Jean Estelle¹,Camoin Laurence²,Ebbo Mikael¹,Harlé Jean-Robert¹,Schleinitz Nicolas¹,Sarlon Gabrielle³,Bernit Emmanuelle¹

Affiliation:

1. Department of Internal Medicine, La Timone Hospital, Marseille, France;

2. Department of Hematology, La Timone Hospital, Marseille, France;

3. Department of Vascular Surgery, La Timone Hospital, Marseille, France

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,Genetics (clinical),Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2019.1689997

Reference15 articles.

1. Global Burden of Sickle Cell Anaemia in Children under Five, 2010–2050: Modelling Based on Demographics, Excess Mortality, and Interventions

2. Sickle cell disease

3. Pulmonary embolism in sickle cell disease: a case-control study

4. Venous Thromboembolism in Adults with Sickle Cell Disease: A Serious and Under-recognized Complication

5. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap;British Journal of Haematology;2024-04-05

2. Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic;Blood Coagulation & Fibrinolysis;2023-09-20

3. Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients;Blood Advances;2023-04-27

4. Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia;Biology;2023-03-23

5. Thrombo-Inflammation in COVID-19 and Sickle Cell Disease: Two Faces of the Same Coin;Biomedicines;2023-01-25